A study of blood sugar reducing effect of Homoeopathic Drug Phosphoricum Acidum 6C under laboratory setting with clinical evaluation of the same in Type 2 Diabetes Mellitus

An In Vitro study of Hypoglycemic effect of Homoeopathic Drug PHOSPHORICUM ACIDUM 6C with In Vivo Evaluation of the same in TYPE 2 DIABETES MELLITUS Patients - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059774

Enrollment

Registered

2023-11-14

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Phosphoricum Acidum: Phosphoricum Acidum 6C in 40 size globules 3 globules twice a day for 5 weeks Control Intervention1: Syzygium Jambolanum: Syzygium Jambolanum Q(Mother Tincture) 5 d

Eligibility

Inclusion criteria

Inclusion criteria: 1.Fasting blood glucose concentration greater than or equal to 135mg/dl 2.Patients those who are willing to give written consent to participate in the study

Exclusion criteria

Exclusion criteria: 1.Cases with other serious illness like carcinomas or severely immune compromised. 2. Chronic smokers and chronic alcoholics. 3. Patients under insulin therapy.

Design outcomes

Primary

Measure	Time frame
1) In Vitro Study (in hyperglycemic blood serum) Title: Reduction in the fasting serum glucose concentration. Description: Glucose Baseline Value - Final Concentration of Glucose Interval: 2 hours. 2) Clinical study Title: Reduction in the fasting serum glucose concentration. Description: Glucose baseline value – Final glucose concentration. Interval: 2 months.Timepoint: After medicinal prescription according to homoeopathic principle mean glucose estimation will be repeated after one week and added 4 weeks of treatment. Obtained values will be taken for analysis.	—

Measure

Time frame

1) In Vitro Study (in hyperglycemic blood serum) Title: Reduction in the fasting serum glucose concentration. Description: Glucose Baseline Value - Final Concentration of Glucose Interval: 2 hours. 2) Clinical study Title: Reduction in the fasting serum glucose concentration. Description: Glucose baseline value – Final glucose concentration. Interval: 2 months.Timepoint: After medicinal prescription according to homoeopathic principle mean glucose estimation will be repeated after one week and added 4 weeks of treatment. Obtained values will be taken for analysis.

—

Secondary

Measure	Time frame
Comparison of Therapeutic effectiveness of Phosphoricum Acidum & Syzygium Jambolanum among the groupTimepoint: After 1 Year (after completion of the study)	—

Countries

India

Contacts

Public ContactDr Vineeth S Nair

Kerala University of Health Science

drjayakishan@gmail.com9446529775

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026